Salvatore Calabrese
2021
In 2021, Salvatore Calabrese earned a total compensation of $345.4K as Chief Financial Officer at Gain Therapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Non-Equity Incentive Plan | $37,389 |
| Salary | $268,000 |
| Total | $345,389 |
Calabrese received $268K in salary, accounting for 78% of the total pay in 2021.
Calabrese also received $40K in bonus and $37.4K in non-equity incentive plan.
Rankings
In 2021, Salvatore Calabrese's compensation ranked 11,423rd out of 12,406 executives tracked by ExecPay. In other words, Calabrese earned more than 7.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,423 out of 12,406 | 8th |
Division Manufacturing | 5,025 out of 5,492 | 9th |
Major group Chemicals And Allied Products | 2,229 out of 2,368 | 6th |
Industry group Drugs | 1,979 out of 2,089 | 5th |
Industry Pharmaceutical Preparations | 1,459 out of 1,536 | 5th |
Source: SEC filing on May 13, 2022.
Calabrese's colleagues
We found two more compensation records of executives who worked with Salvatore Calabrese at Gain Therapeutics in 2021.